Logo image of XPOF

XPONENTIAL FITNESS INC-A (XPOF) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:XPOF - US98422X1019 - Common Stock

8.13 USD
-0.02 (-0.25%)
Last: 1/8/2026, 8:16:19 PM
8.13 USD
0 (0%)
After Hours: 1/8/2026, 8:16:19 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to XPOF. XPOF was compared to 133 industry peers in the Hotels, Restaurants & Leisure industry. While XPOF is still in line with the averages on profitability rating, there are concerns on its financial health. XPOF has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year XPOF was profitable.
XPOF had a positive operating cash flow in the past year.
In the past 5 years XPOF reported 4 times negative net income.
Of the past 5 years XPOF 4 years had a positive operating cash flow.
XPOF Yearly Net Income VS EBIT VS OCF VS FCFXPOF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

XPOF has a worse Return On Assets (-15.44%) than 87.22% of its industry peers.
XPOF has a better Return On Invested Capital (22.15%) than 93.23% of its industry peers.
The Average Return On Invested Capital over the past 3 years for XPOF is in line with the industry average of 10.39%.
The last Return On Invested Capital (22.15%) for XPOF is above the 3 year average (10.38%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -15.44%
ROE N/A
ROIC 22.15%
ROA(3y)-5.36%
ROA(5y)-7.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.38%
ROIC(5y)N/A
XPOF Yearly ROA, ROE, ROICXPOF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

XPOF has a better Operating Margin (23.27%) than 87.97% of its industry peers.
XPOF's Gross Margin of 78.16% is amongst the best of the industry. XPOF outperforms 92.48% of its industry peers.
In the last couple of years the Gross Margin of XPOF has grown nicely.
Industry RankSector Rank
OM 23.27%
PM (TTM) N/A
GM 78.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.58%
GM growth 5Y3.29%
XPOF Yearly Profit, Operating, Gross MarginsXPOF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), XPOF is creating value.
The number of shares outstanding for XPOF has been increased compared to 1 year ago.
Compared to 5 years ago, XPOF has more shares outstanding
Compared to 1 year ago, XPOF has a worse debt to assets ratio.
XPOF Yearly Shares OutstandingXPOF Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
XPOF Yearly Total Debt VS Total AssetsXPOF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

XPOF has an Altman-Z score of -0.69. This is a bad value and indicates that XPOF is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of XPOF (-0.69) is worse than 86.47% of its industry peers.
The Debt to FCF ratio of XPOF is 25.96, which is on the high side as it means it would take XPOF, 25.96 years of fcf income to pay off all of its debts.
XPOF's Debt to FCF ratio of 25.96 is in line compared to the rest of the industry. XPOF outperforms 45.86% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 25.96
Altman-Z -0.69
ROIC/WACC2.12
WACC10.43%
XPOF Yearly LT Debt VS Equity VS FCFXPOF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

2.3 Liquidity

A Current Ratio of 1.06 indicates that XPOF should not have too much problems paying its short term obligations.
XPOF has a Current ratio (1.06) which is comparable to the rest of the industry.
A Quick Ratio of 1.00 indicates that XPOF should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.00, XPOF perfoms like the industry average, outperforming 57.89% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 1
XPOF Yearly Current Assets VS Current LiabilitesXPOF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 23.53% over the past year.
Looking at the last year, XPOF shows a decrease in Revenue. The Revenue has decreased by -3.36% in the last year.
The Revenue has been growing by 19.93% on average over the past years. This is quite good.
EPS 1Y (TTM)23.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%950%
Revenue 1Y (TTM)-3.36%
Revenue growth 3Y27.35%
Revenue growth 5Y19.93%
Sales Q2Q%-2.07%

3.2 Future

Based on estimates for the next years, XPOF will show a very strong growth in Earnings Per Share. The EPS will grow by 113.48% on average per year.
The Revenue is expected to grow by 1.39% on average over the next years.
EPS Next Y353.54%
EPS Next 2Y232.16%
EPS Next 3Y167.16%
EPS Next 5Y113.48%
Revenue Next Year-3.89%
Revenue Next 2Y-2.39%
Revenue Next 3Y2.66%
Revenue Next 5Y1.39%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
XPOF Yearly Revenue VS EstimatesXPOF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M
XPOF Yearly EPS VS EstimatesXPOF Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 38.71, XPOF can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as XPOF.
Compared to an average S&P500 Price/Earnings ratio of 27.00, XPOF is valued a bit more expensive.
The Price/Forward Earnings ratio is 9.00, which indicates a very decent valuation of XPOF.
Based on the Price/Forward Earnings ratio, XPOF is valued cheaply inside the industry as 93.23% of the companies are valued more expensively.
XPOF's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.70.
Industry RankSector Rank
PE 38.71
Fwd PE 9
XPOF Price Earnings VS Forward Price EarningsXPOF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, XPOF is valued a bit cheaper than the industry average as 78.95% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of XPOF indicates a somewhat cheap valuation: XPOF is cheaper than 64.66% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 28.75
EV/EBITDA 8.16
XPOF Per share dataXPOF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 -6

4.3 Compensation for Growth

XPOF's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
XPOF's earnings are expected to grow with 167.16% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.11
PEG (5Y)N/A
EPS Next 2Y232.16%
EPS Next 3Y167.16%

0

5. Dividend

5.1 Amount

XPOF does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

XPONENTIAL FITNESS INC-A

NYSE:XPOF (1/8/2026, 8:16:19 PM)

After market: 8.13 0 (0%)

8.13

-0.02 (-0.25%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)03-11 2026-03-11/amc
Inst Owners81.49%
Inst Owner Change0%
Ins Owners5.46%
Ins Owner Change25.33%
Market Cap397.64M
Revenue(TTM)315.73M
Net Income(TTM)-54.86M
Analysts78.75
Price Target11.12 (36.78%)
Short Float %22.54%
Short Ratio9.16
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.12
Dividend Growth(5Y)N/A
DP-14.03%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)94.37%
Min EPS beat(2)16.62%
Max EPS beat(2)172.11%
EPS beat(4)2
Avg EPS beat(4)-44.73%
Min EPS beat(4)-219.74%
Max EPS beat(4)172.11%
EPS beat(8)2
Avg EPS beat(8)-60.28%
EPS beat(12)2
Avg EPS beat(12)-153.22%
EPS beat(16)2
Avg EPS beat(16)-143.54%
Revenue beat(2)1
Avg Revenue beat(2)-0.29%
Min Revenue beat(2)-3.27%
Max Revenue beat(2)2.69%
Revenue beat(4)3
Avg Revenue beat(4)0%
Min Revenue beat(4)-3.27%
Max Revenue beat(4)2.69%
Revenue beat(8)5
Avg Revenue beat(8)-0.02%
Revenue beat(12)9
Avg Revenue beat(12)1.8%
Revenue beat(16)13
Avg Revenue beat(16)4.72%
PT rev (1m)-1.8%
PT rev (3m)-11.62%
EPS NQ rev (1m)-186.68%
EPS NQ rev (3m)-113.42%
EPS NY rev (1m)-17.6%
EPS NY rev (3m)-39.13%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.84%
Revenue NY rev (1m)0.12%
Revenue NY rev (3m)-0.11%
Valuation
Industry RankSector Rank
PE 38.71
Fwd PE 9
P/S 1.26
P/FCF 28.75
P/OCF 21.61
P/B N/A
P/tB N/A
EV/EBITDA 8.16
EPS(TTM)0.21
EY2.58%
EPS(NY)0.9
Fwd EY11.11%
FCF(TTM)0.28
FCFY3.48%
OCF(TTM)0.38
OCFY4.63%
SpS6.46
BVpS-2.32
TBVpS-6.31
PEG (NY)0.11
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -15.44%
ROE N/A
ROCE 28.03%
ROIC 22.15%
ROICexc 26.31%
ROICexgc 227.32%
OM 23.27%
PM (TTM) N/A
GM 78.16%
FCFM 4.38%
ROA(3y)-5.36%
ROA(5y)-7.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.38%
ROIC(5y)N/A
ROICexc(3y)11.53%
ROICexc(5y)N/A
ROICexgc(3y)87.99%
ROICexgc(5y)N/A
ROCE(3y)13.14%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.58%
GM growth 5Y3.29%
F-Score5
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 25.96
Debt/EBITDA 3.98
Cap/Depr 32.33%
Cap/Sales 1.45%
Interest Coverage 1.77
Cash Conversion 21%
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 1
Altman-Z -0.69
F-Score5
WACC10.43%
ROIC/WACC2.12
Cap/Depr(3y)65.89%
Cap/Depr(5y)60.54%
Cap/Sales(3y)3.86%
Cap/Sales(5y)3.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%950%
EPS Next Y353.54%
EPS Next 2Y232.16%
EPS Next 3Y167.16%
EPS Next 5Y113.48%
Revenue 1Y (TTM)-3.36%
Revenue growth 3Y27.35%
Revenue growth 5Y19.93%
Sales Q2Q%-2.07%
Revenue Next Year-3.89%
Revenue Next 2Y-2.39%
Revenue Next 3Y2.66%
Revenue Next 5Y1.39%
EBIT growth 1Y3.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year471.16%
EBIT Next 3Y96.1%
EBIT Next 5Y67.63%
FCF growth 1Y-65.44%
FCF growth 3Y-17.41%
FCF growth 5YN/A
OCF growth 1Y-64.87%
OCF growth 3Y-6.86%
OCF growth 5Y49.76%

XPONENTIAL FITNESS INC-A / XPOF FAQ

Can you provide the ChartMill fundamental rating for XPONENTIAL FITNESS INC-A?

ChartMill assigns a fundamental rating of 4 / 10 to XPOF.


Can you provide the valuation status for XPONENTIAL FITNESS INC-A?

ChartMill assigns a valuation rating of 6 / 10 to XPONENTIAL FITNESS INC-A (XPOF). This can be considered as Fairly Valued.


How profitable is XPONENTIAL FITNESS INC-A (XPOF) stock?

XPONENTIAL FITNESS INC-A (XPOF) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for XPOF stock?

The Price/Earnings (PE) ratio for XPONENTIAL FITNESS INC-A (XPOF) is 38.71 and the Price/Book (PB) ratio is -3.5.


Can you provide the dividend sustainability for XPOF stock?

The dividend rating of XPONENTIAL FITNESS INC-A (XPOF) is 0 / 10 and the dividend payout ratio is -14.03%.